RLMD
Relmada Therapeutics Inc.
$7.17
+$0.13(+1.85%)
50
Overall
60
Value
63
Tech
28
Quality
Market Cap
$50.78M
Volume
726.37K
52W Range
$0.36 - $8.00
Target Price
$12.80
Key Metrics Overview
| Market Cap | $50.78M | P/E Ratio | N/A |
| 52W High | $8.00 | 52W Low | $0.36 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | 35.1% | 52W Position | 89.1% |
| Overall Score | 50 | Value Score | 60 |
| Quality Score | 28 | Technical Score | 63 |
Growth Analysis
| EPS Current Est | $-0.76 | EPS Next Est | $-1.19 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RLMD | $7.17 | +1.8% | 726.37K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Relmada Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW